MedPage Today on MSN
NEJM retracts pivotal trial of FDA-approved drug
Move follows actions "inconsistent with proper research conduct," journal says ...
Stoboclo and Osenvelt were approved as interchangeable biosimilars for bone loss conditions, potentially reducing costs and increasing access. Darzalex Faspro was approved for high-risk smoldering ...
Alembic has received approval for generic Retin-A-Cream and generic Haldol tablets, and tentative approval for generic Vitrakvi.
Lupin Limited has received tentative approval from the FDA for its abbreviated new drug application (ANDA) for enzalutamide ...
Illustration of New Drug Application paperwork surrounded by pills, vials, and DNA. The US Food and Drug Administration approved 46 new molecular entities in 2025. Credit: C&EN/Shutterstock The year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results